- $16.14bn
- $18.71bn
- $8.25bn
U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National
U.S. STOCKS ON THE MOVE-Iron Mountain, BridgeBio, Old Dominion,
U.S. STOCKS ON THE MOVE-PPG Industries, American Electric Power, West Pharmaceutical
U.S. STOCKS ON THE MOVE-Cisco Systems, Viking Therapeutics, Albemarle
ICON slumps as audit probe finds signs of overstated revenue
Life sciences and contract research stocks navigate turbulence in 2025
Brief: Icon Survey Reveals Increasing Clinical Trial Startup Delays
U.S. STOCKS ON THE MOVE- Shoe Carnival, Leidos Holdings, copper miners
Brief: Icon Confirms No Change In FY 2025 Financial Guidance
U.S. STOCKS ON THE MOVE- Gap, Aquestive Therapeutics, Lumentum
ICON falls after CEO transition
ICON falls after CEO transition
IQVIA names Michael Fedock as financial chief
ICON falls as COVID vaccine study paused by US funding agency
Charles River profit forecast clouded by order cancellations from biotechs (updated)
Contract research firms' strong earnings signal stabilizing biotech, pharma spending
Icon Plc Reports Results For The Quarter Ended June 30: Earnings Summary
Icon Plc Expected To Post Earnings Of $3.21 A Share: Earnings Preview
Icon Plc Reports Results For The Quarter Ended March 31: Earnings Summary